In Silico study of ivermectin, camostat, and nafamostat, showing that ivermectin had the best inhibitory action on the SARS-CoV-2 spike protein and Nsp10, while nafamostat had the best results for the other non-structural proteins. Authors note that the combination of ivermectin and nafamostat may be beneficial for COVID-19.
Umar et al., 30 Jun 2022, peer-reviewed, 6 authors.
In Silico studies are an important part of preclinical research, however results may be very different in vivo.